A note on the nature of utility in time and health and implications for cost utility analysis

被引:14
|
作者
Buckingham, Ken J. [2 ]
Devlin, Nancy Joy [1 ]
机构
[1] City Univ London, Dept Econ, London EC1 V OHB, England
[2] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand
关键词
Time Trade-Off (TTO); Utility; QALYs; Cost utility analysis; Maximal endurable time; QUALITY-OF-LIFE; EXTRA-WELFARISM; STATES WORSE; TRADE-OFF; PREFERENCES; VALUATIONS; VALIDITY; QALYS; DEATH; MODEL;
D O I
10.1016/j.socscimed.2008.09.048
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Time Trade-Off (TTO) valuations of health are widely used in economic evaluation of health care. Current approaches to eliciting TTO values, and their use in economic evaluation, rest on specific assumptions about the way utility relates to time and health. Both the assumptions themselves and evidence of violations of them are discussed in the literature - yet the issues appear not to be widely appreciated by those using and applying TTO in economic evaluation. This paper adds to that literature by demonstrating both the requirements of TTO and violations of these assumptions in terms of the underlying indifference curve maps and utility functions. The advantage of this approach is that it demonstrates very clearly a number of fundamental problems for the way TTO values are currently elicited and used in cost utility analysis. In essence, it is extremely unwise to assume that the current 'tariffs' of TTO values, such as those widely used in cost utility analysis to inform health sector decisions in many countries can be applied irrespective of the duration of the health states to which they are assigned. The estimates of QALYs that result will, quite often, simply be wrong. We conclude by pointing to a number of possible solutions. (C) 2008 Published by Elsevier Ltd.
引用
收藏
页码:362 / 367
页数:6
相关论文
共 50 条
  • [21] A second opinion - Cost-utility analysis and varying preferences for health
    Mooney, G
    Jan, S
    HEALTH POLICY, 1997, 41 (03) : 201 - 203
  • [22] COST-UTILITY ANALYSIS IN THE EVALUATION OF PERINATAL HEALTH-CARE
    DERHAM, R
    LANCET, 1986, 2 (8503): : 399 - 399
  • [23] The QALY model: Utilities for cost-utility analysis in health care
    Fryback, DG
    DECISION SCIENCE AND TECHNOLOGY: REFLECTIONS ON THE CONTRIBUTIONS OF WARD EDWARDS, 1999, : 331 - 351
  • [24] Cost utility analysis of erythropoietin therapy in the ministry of health dialysis programme
    Yusof, Aryani Md. F.
    Goh, A.
    Lim, T. O.
    VALUE IN HEALTH, 2006, 9 (06) : A387 - A388
  • [25] COMPARISON OF HEALTH STATE UTILITY ESTIMATES IN COST-EFFECTIVENESS ANALYSIS
    Slejko, J. F.
    Ghushchyan, V. H.
    Sullivan, P. W.
    VALUE IN HEALTH, 2010, 13 (03) : A13 - A13
  • [26] THE TENSION BETWEEN COST-UTILITY ANALYSIS AND PREVENTIVE PUBLIC HEALTH
    Hyun, I.
    MEDICINE AND LAW, 2006, 25 (03): : 483 - 490
  • [27] A MISSING DATA THRESHOLD AS APPLIED TO HEALTH OUTCOMES DATA: DIFFERENTIAL IMPLICATIONS FOR COST-UTILITY ANALYSIS BY DIAGNOSIS
    Bush, S.
    VALUE IN HEALTH, 2008, 11 (06) : A560 - A560
  • [28] Cost-utility analysis and otolaryngology
    Hamilton, D.
    Hulme, C.
    Flood, L.
    Powell, S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2014, 128 (02): : 112 - 118
  • [29] Cost-utility analysis in schizophrenia
    Awad, AG
    Voruganti, LP
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 22 - 28
  • [30] COST-UTILITY ANALYSIS IN UROLOGY
    Fero, Katherine
    Sharma, Vidit
    Lec, Patrick
    Saigal, Christopher
    Chamie, Karim
    JOURNAL OF UROLOGY, 2021, 206 : E435 - E436